The Robyn Denholm-chaired Strategic Examination of R&D (SERD) has been circulated among government MPs and senators and will be released “well ahead” of the May federal Budget. Industry and...
Australia’s subscale capabilities in developing new drugs will need smart policy and emerging tech to bridge the decade-long divide between medical research and commercialisation. That’s according to Dr Craig...
The Albanese government will cut $102 million in uncommitted funding from its flagship early-stage commercialisation initiative designed to help startups bridge the funding gap. The Industry Growth Program (IGP)...
A once-in-a-generation review of Australia’s research and development system has been completed and delivered to the Albanese government, but won’t be released until next year. The Strategic Examination of...
The Strategic Examination of R&D (SERD), announced by the Department of Industry, Science and Resources in February of this year, begins with the statement: “The immense potential of Australian...
The national science agency will not launch any more large scale research missions and is folding current ones like ending plastic waste and achieving net zero into its regular...
In Australian politics, we talk a lot about innovation. But too often, we forget what actually drives it: private sector capital. As economist Joseph Schumpeter wrote, “the capitalist engine...
Major Australian science groups are warning the government’s generational review of research and development is overlooking discovery work, threatening Australia’s “wellspring of innovation”. The Australian Academy of Science on...
Scientists have sounded the alarm that a generational review of Australia’s research and development system is off course and could plant the seeds of another blue sky funding crunch....
The Economic Reform Roundtable was pitched as a pivotal moment for Australia’s economic future. But ambition alone won’t lift productivity. If the roundtable is to matter, it must now...